Tag Archives: Investing

Snowflake (SNOW) Posts Strong Q2, Eyes Deeper AI Integration — Here’s Why It’s Catching Investor Interest

Posted on by
Reply

Snowflake Inc. (NYSE: $SNOW) released its second quarter (fiscal 2026) results, reinforcing its role as a data and AI infrastructure play while navigating challenges in profitability and valuation. The reaction in markets suggests that investors are increasingly viewing Snowflake as more than just a cloud data warehousing provider — but as a core enabler of “AI Data Cloud” strategies. Here’s a breakdown of what’s happening, and the bull vs bear cases moving forward.

What the Numbers Say: Q2 & Recent Financials

Revenue, Margins & Growth

  • In Q2 FY2026, Snowflake reported product revenue of $1,090.5 million (i.e. from compute, storage, and data transfer). (Snowflake Investors)
  • The company continues to emphasize net revenue retention, which remains elevated (125%) as of July 31, 2025 — indicating that existing customers are expanding usage. (Snowflake Investors)
  • In its Q4 FY2025 results (ended January 31, 2025), Snowflake posted total revenue of $986.8 million, with product revenue of $943.3 million — up ~28% year-over-year. (Snowflake)
  • The Q4 gross profit margin (GAAP) was ~ 66%, and non-GAAP adjusted gross margin (excluding stock-based comp, amortization, etc.) was ~ 73%. (Snowflake)
  • Snowflake’s Q4 operating loss (GAAP) was about –$386.7 million, but on a non-GAAP basis it posted operating income of $92.8 million (≈ 9% margin). (Snowflake)
  • Its free cash flow in that quarter was ~$415.4 million (≈ 42% of revenue) and adjusted free cash flow ~$423.1 million. (Snowflake)

These numbers show both strength and tension: strong top-line growth and healthy non-GAAP profit conversions, but continued GAAP losses driven by sizable investments, stock compensation, and amortization.

Balance Sheet & Liquidity

  • As of January 31, 2025, Snowflake held ~$2,698.7 million in cash, cash equivalents, and restricted cash. (Snowflake)
  • Total debt (short-term + long-term) is more modest — for example, in recent annual balance sheet summaries, SNOW’s short-term and current portion of long-term debt is listed in the range of ~ $36 million. (The Wall Street Journal)
  • On the assets side, total assets are in the realm of several billions (over $8B to $9B in some reports) with growth trends consistent among public disclosures. (Investing.com+1)
  • The company carries significant liabilities as well (deferred revenue, vendor payables, deferred costs), but its liquidity cushion offers some buffer against short-term shocks. (Investing.com)

Business & Strategic Metrics

  • Snowflake’s remaining performance obligations (RPO) — i.e., contracted but not-yet-recognized revenue — stood at $6.9 billion, growing ~33% year-over-year. (Snowflake)
  • The company serves 580 customers whose trailing 12-month product revenues exceed $1 million, and 745 Forbes Global 2000 customers as of Q4 FY2025. (Snowflake)
  • The 125% dollar-based net revenue retention underlines that Snowflake is often able to upsell or expand within its installed base. (Snowflake Investors)
  • More recently, Snowflake announced its acquisition of Crunchy Data (for ~ $250 million) to integrate Postgres capabilities into its ecosystem, enabling developers to more easily build AI agents and manage data workloads. (The Wall Street Journal+1)
  • The company is also partnering or aligning more closely with AI/LLM providers (e.g., Anthropic), seeking to embed language model capabilities into its platform. (Reuters+2markets.businessinsider.com+2)

What’s Driving the Recent Move & Market Sentiment

In response to its Q4 FY2025 earnings (released earlier in 2025), Snowflake’s stock jumped ~10.9% after hours, as the company beat on earnings (30 cents per share vs ~18 cents expected) and revenue (nearly $987 million vs $957 million consensus). Barron’s It also raised its forecast for product revenue and delivered upbeat guidance for FY2026, projecting ~24% growth to ~$4.28 billion. (MarketWatch+2Barron’s+2)

Investors have taken notice of Snowflake’s push into AI, including more sophisticated integrations with large language models, and its efforts to position itself not just as a data platform but an “AI data cloud” enabler. (markets.businessinsider.com+2Reuters+2)

That said, concerns still linger over valuation multiples (Snowflake trades at high forward multiples), GAAP losses, and macro risk to enterprise IT spending.

Why Some Investors Might Find SNOW Attractive (and Its Risks)

Bull Case

  1. Exposure to Secular Trends in Data + AI
    As enterprises shift toward AI, data modeling, real-time analytics, and agent-based applications, Snowflake sits at a nexus: you need scalable, secure data infrastructure. Its existing customer base, product maturity, and retention metrics lend credibility to that positioning.
  2. Upsell & Expansion Potential
    Snowflake’s high net revenue retention and expanding average spend per customer suggest that a lot of value lies in selling more compute/storage or ancillary AI features to its installed base.
  3. Strategic Acquisitions & Technology Stack Expansion
    The Crunchy Data deal, combined with its AI platform integrations, may help lock in more workloads (especially developer, data app, and AI agent workloads) and reduce friction for adoption.
  4. Cash Generative Capacity (Non-GAAP / FCF)
    Despite GAAP losses, Snowflake has shown strong adjusted free cash flow generation, which gives it flexibility to invest, defend, or expand without complete reliance on external financing.
  5. Backlog / Contracted Revenue Visibility
    The RPO metric provides a view into future revenue, giving some predictability to growth expectations and lessening the reliance purely on new deals.

Risks & Challenges

  • Profitability & Cost Pressure
    Snowflake still runs GAAP losses. Its heavy investment in R&D, sales & marketing, and stock-based compensation make margins sensitive. If growth slows, the pressure on margins will intensify.
  • Valuation Overhang
    At high multiples, the stock’s valuation leaves little room for mistakes. A small slip in guidance or macro softness in enterprise IT spending could cause multiple compression.
  • Competition & Execution Risk
    The competitive landscape is fierce (e.g. Databricks, AWS, Google, Microsoft) and execution (product development, scaling, integrating acquisitions) will matter enormously.
  • Dependence on Cloud Providers
    Snowflake relies on underlying public clouds (AWS, Azure, GCP) for infrastructure. Any changes in pricing, caps, or ecosystem dynamics could affect its cost structure or competitiveness. (Wikipedia+1)
  • Macro / IT Spend Weakness
    In a downturn or with tightening enterprise budgets, large IT and data platform spends may get deferred, impacting growth.
  • Integration and Engineering Complexity
    Adding deeper database, AI, and application layers increases complexity — integrating acquisitions and maintaining stability and performance across features will be demanding.

Outlook & Near-Term Catalysts

  • Snowflake’s guidance for Q1 FY2026 product revenue is in the range $955 million to $960 million. (Snowflake)
  • For full-year FY2026, the company expects ~ 24% product revenue growth to ~$4.28 billion, with non-GAAP product gross margins reaching ~75%. (Snowflake)
  • The success of its Crunchy Data acquisition (Postgres integration), traction of AI integrations (e.g., embedding LLMs for analytics), and customer growth in large enterprises will be closely watched.

If Snowflake can continue delivering above expectations on product revenue, manage its cost base, and ensure that its AI/data additions translate into incremental revenue without diluting execution, it may justify its premium valuation post its recent run.

Verdict & Investor Fit

Snowflake is not a “safe” stock in the sense of predictable earnings or low volatility, but it is a compelling pick for investors with conviction in the data + AI transition and a willingness to ride through lumps. For those looking for asymmetric upside exposure to the AI/data infrastructure stack, SNOW has a profile worth watching — especially if bought during periods of market softness.

Disclosure:

I do not own any stock or have any financial interest in Snowflake Inc. (NYSE: $SNOW). This article is for informational purposes only and should not be considered financial or investment advice. Investing in stocks carries risks, and past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial professional before making any investment decisions.

Barron’s. (2025, August 28). Snowflake stock jumps after earnings beat. Here’s what analysts are saying. Dow Jones & Company. https://www.barrons.com/articles/snowflake-stock-price-earnings-ai-1f2b9a5e

MarketWatch. (2025, August 28). Snowflake’s earnings and revenue beat expectations. Dow Jones & Company. https://www.marketwatch.com/story/snowflakes-earnings-and-revenue-beat-expectations-11695946094

Snowflake Inc. (2025, August 28). Snowflake reports second quarter fiscal 2025 financial results [Press release]. Snowflake Investor Relations. https://investors.snowflake.com/

Yahoo Finance. (2025). Snowflake Inc. (SNOW) financials. Retrieved September 27, 2025, from https://finance.yahoo.com/quote/SNOW/financials

Exploring Investment Strategies: How to Start with Just $1,000

Posted on by
Reply

Many people believe you need a large sum of money to start investing, but the truth is you can begin building wealth with as little as $1,000. The key lies in choosing the right strategy that fits your goals, risk tolerance, and timeline.

1. Index Funds

Index funds are one of the simplest and most effective ways to invest. By tracking the performance of a broad market index (like the S&P 500), they offer diversification and steady long-term growth. Historically, index funds have returned around 7–10% annually. With $1,000 invested, the potential compound growth over 10 years could more than double your money.

2. Dividend Stocks

Dividend-paying stocks provide the dual benefit of potential stock price appreciation and regular income through dividend payouts. This strategy appeals to investors who want to generate passive income while also building long-term value. Though returns may vary, reinvesting dividends can accelerate portfolio growth.

3. Bonds

For those seeking stability, bonds remain a trusted option. While the returns are lower compared to stocks, they provide predictable income and are less volatile. A $1,000 bond investment won’t skyrocket in value, but it can help protect capital while earning modest interest.

4. High-Yield Savings Accounts

Technically not an investment in the traditional sense, high-yield savings accounts are a safe place to grow your money while maintaining liquidity. While returns are the smallest of the group, they offer security and immediate access to funds, which is ideal for short-term goals.

Bottom Line

Starting with $1,000 may not make you rich overnight, but it sets the foundation for long-term financial growth. By choosing a strategy that aligns with your needs—whether it’s the steady growth of index funds, the income from dividends, the safety of bonds, or the liquidity of savings—you can begin your journey to building wealth today.

Conduent Incorporated ($CNDT): Q2 2025 Snapshot, Balance-Sheet Health, and Where the Stock Stands for Gains

Posted on by
Reply

Conduent Incorporated, the business-process-services company spun out from Xerox, reported mixed results through early 2025 as it works to convert cost cuts and restructuring into sustainable profit. The shares trade at a low single-digit price level, making the company a high-beta, speculative play for investors who believe management can consistently deliver margin improvement and free cash flow growth. (Conduent Investor)

Key headlines (what just happened)

  • Conduent reported second-quarter 2025 results in early August with revenue of roughly $754 million and GAAP net loss on a standalone basis (but continued improvements in adjusted metrics were highlighted by management). (Conduent Investor)
  • The company’s market capitalization sits in the hundreds of millions (Yahoo Finance shows market cap in the ~$440–460M range around current quotes), while enterprise value is notably higher because of net debt on the balance sheet. The stock price is trading near $2.80–$3.00 per share as of this writing. (Yahoo Finance)

Balance-sheet and financial-position analysis

Using the company filings and aggregated financial data, the balance-sheet picture for Conduent in the most recent filings shows several important characteristics:

  • Total assets / liabilities: Conduent’s total assets in recent annual/quarterly filings have been in the low-to-mid billions (annual totals around $2.6B–$3.2B), with total liabilities making up a substantial portion of that base. That translates to relatively thin shareholder equity compared with larger peers. (Yahoo Finance+1)
  • Leverage / net debt: Total long-term debt has historically been material — recent snapshots put total debt roughly in the high hundreds of millions to over $1B (enterprise value and total debt differ by source and date) — and net cash/(debt) has been negative (i.e., net debt). StockAnalysis and other aggregators show net debt in the several-hundred-million range. That means Conduent’s EV is meaningfully larger than its market cap. (StockAnalysis+1)
  • Liquidity: Management has emphasized cash on hand and the revolving credit facility as sources of near-term liquidity in SEC filings and the latest 10-Q/earnings commentary; operating cash flow is a key metric to watch as the company seeks to deleverage. The company stated it believes its cash, projected operating cash flow and its revolving credit line support near-term needs. (Conduent Investor+1)

Interpretation: Conduent is a balance-sheet–constrained turnaround: not insolvent, but carrying leverage that raises the bar for operational execution. If revenue growth stalls or free cash flow fails to materialize, debt servicing and refinancing risk become real constraints.

Income-statement & cash-flow highlights

  • Revenue trend: Revenues have been in the ~$3.3B range on an annual basis (2023–2024 levels per public filings and financial aggregators), with sequential quarter fluctuations due to contract timing and divestitures. Recent quarters in 2025 showed revenue in the mid-$700M range per quarter. (Yahoo Finance+1)
  • Profitability: GAAP results have cycled between losses and small profits in recent years; management prefers adjusted EBITDA/adjusted metrics that show margin improvement after restructuring. For investors, the question is whether adjusted profit improvement converts to consistent GAAP profitability and positive operating cash flow. (Conduent Investor+1)
  • Cash flow: Free-cash-flow generation has been variable. The company highlights projected cash flow from operations as a pillar of its liquidity, but historical net debt and working-capital swings mean investors should track quarterly cash-flow statements, not just headline operating results. (Conduent Investor+1)

Valuation and risks

  • Valuation: On a trailing basis Conduent’s P/E (when positive) and EV multiples are compressed versus stable peers because of the elevated leverage and inconsistent earnings. Market cap (sub-$500M range) compared with enterprise value near ~$1B indicates investors price in significant debt and execution risk. (Yahoo Finance+1)
  • Catalysts for upside: sustained adjusted-EBITDA growth, consistent GAAP profitability, meaningful free cash flow, and visible debt reduction would be strong upside catalysts. Contract wins or higher-margin mix (e.g., digital-services expansion) could improve investor sentiment. (Conduent Investor)
  • Downside risks: failure to convert adjusted metrics to real cash, large contract losses, macro pressure on customers (public-sector budgets, transportation spending shifts), or refinancing stress on debt.

Recommendation (straight answer)

  • For conservative investors: Conduent is not suitable. The balance sheet shows leverage and earnings volatility; until management demonstrably converts adjusted profits into recurring GAAP profits and consistent positive free cash flow, the stock is a speculative holding at best. (StockAnalysis+1)
  • For risk-tolerant investors / traders seeking gains: Conduent’s low absolute market cap and depressed share price create asymmetric upside if execution improves. That makes it a potential high-risk, event-driven trade — buy only a small allocation, be prepared for high volatility, and plan an exit strategy tied to specific milestones (e.g., two to three consecutive quarters of positive operating cash flow or a material debt-reduction announcement). Use strict position sizing and stop rules. (Conduent Investor)

What to watch next (actionable checklist)

  1. Quarterly cash-flow from operations (is it consistently positive?). (Conduent Investor)
  2. Net debt trend — any sustained debt paydown or refinancing on better terms. (StockAnalysis)
  3. Revenue mix — growth in higher-margin digital services vs. legacy BPO work. (Conduent Investor)
  4. Management commentary & guidance (next earnings call / 10-Q updates). (Conduent Investor+1)

Sources and Transparency

This article relied on Conduent’s investor relations releases and SEC filings, plus market data aggregators (Yahoo Finance, StockAnalysis, Macrotrends, Nasdaq) for pricing, market cap and historical financial statements. Key sources: Conduent investor releases and 10-Q/10-K filings, Yahoo Finance price & key statistics, and StockAnalysis balance-sheet pages. (StockAnalysis+3Conduent Investor+3Conduent Investor+3)

Bottom line: Conduent is a turnaround story with a leveraged balance sheet. If you believe management will convert improved adjusted margins into recurring cash and pay down debt, the stock offers speculative upside from a depressed base. If you require capital preservation and predictable returns, this is better left alone. Keep position sizing small, watch cash flow and net-debt trends, and tie any buy decision to concrete operational milestones. (Conduent Investor+1)

References

Conduent Incorporated. (2025, August 6). Conduent reports second quarter 2025 results [Press release]. Conduent Investor Relations. https://investor.conduent.com

Conduent Incorporated. (2025). Form 10-Q for the quarterly period ended June 30, 2025. U.S. Securities and Exchange Commission. https://www.sec.gov

Macrotrends LLC. (2025). Conduent balance sheet 2016–2025 (CNDT). Macrotrends. https://www.macrotrends.net

Nasdaq, Inc. (2025). Conduent Incorporated (CNDT) income statement. Nasdaq. https://www.nasdaq.com

StockAnalysis. (2025). Conduent (CNDT) financials, balance sheet & ratios. StockAnalysis. https://stockanalysis.com

Yahoo Finance. (2025). Conduent Incorporated (CNDT) stock price, quote, and news. Yahoo! Finance. https://finance.yahoo.com

📈 Why Target $TGT Could Be a Solid Income + Growth Pick

Posted on by
Reply

High Dividend Yield & Track Record
Target currently pays $4.56 annually ($1.14 per quarter), translating into a robust ~4.9% yield on today’s ~$93 share price (StockAnalysisTipRanks). The company has increased its dividend for 54 consecutive years, a hallmark Dividend King that inspires investor confidence (NasdaqStockAnalysis). Its most recent raise (1.8%) was declared in June 2025, effective with the $1.14 quarterly payment on Sept 1, 2025 (ex-div Aug 13) (Target Corporation).

Payout Coverage & Sustainability
Target retains a payout ratio of roughly 52%—meaning it distributes just over half of earnings as dividends, leaving room to reinvest and buffer downturns (KoyfinStockAnalysis). It also generated ~$2.9 B in free cash flow over the past 12 months, comfortably above its roughly $2 B annual dividend obligation (Nasdaq).

Valuation Lean vs Peers
At a P/E near 11×, Target trades well below peers like Walmart (~37×), suggesting the market has priced in current headwinds—offering potential upside if operational trends normalize over time (Nasdaq).

🧾 Balance Sheet Overview (as of latest trailing 12 mo / August 2025)

Based on S&P-compiled data (StockAnalysisMarketBeat):

📌 Metric💰 Value (USD mm)
Total Assets~$57.9 B
Cash & Equivalents~$4.34 B
Inventories~$12.9 B
PPE (net)~$33.6 B
Total Liabilities~$42.4 B
└ Current Liabilities~$19.2 B
└ Long-Term Debt~$15.4 B
Shareholders’ Equity~$15.4 B (book value ~ $33.9/share)
Net Debt~$16.1 B

Target maintains a healthy asset base, anchored by substantial property, inventory, and cash buffers. Long‐term debt is sizable but manageable given recurring cash flow. Equity has grown steadily (~$14.7 B in FY 2024 to ~$15.4 B TTM), with tangible book value per share near $34—over one-third of share price (StockAnalysis).

🔍 Business Momentum & Outlook

  • Recent performance (Q2 FY 2025):
    Net sales declined ~0.9% YoY and comp sales fell ~1.9%, though digital sales rose ~4.3%. Operating income slipped ~19% to $1.3 B. Full-year EPS guidance remains at $8.00–$10.00 GAAP (adjusted ~$7–$9) (Target Corporation).
  • Strategic tailwinds:
    Investments in same-day fulfillment via Shipt, modernization of logistics, and omnichannel integration are expected to drive margin recovery (expected to improve toward ~6% by FY 2028) (University of Iowa).

💡 Investment Case: Why Consider TGT

  1. Reliable, high income: ~4.9–5.0% yield, backed by decades of increases.
  2. Dividend sustainability: Strong cash flow vs payout; modest payout ratio.
  3. Undemanding valuation: Trading at low P/E, offering value if business stabilizes.
  4. Solid balance sheet: Ample liquidity, reasonable leverage, growing equity.
  5. Long-term turnaround potential: Operational improvements could bolster margins and share price over time.

Risks include macro-sensitive retail environment, margin pressures, inventory mismanagement, and stiff competition. However, the dividend acts as a buffer while strategic moves take root.

📌 Bottom Line

For income-focused investors looking to pair dividend yield with capital appreciation potential, Target (TGT) stands out as a compelling blended opportunity. Its long-standing dividend credibility, backed by solid free cash flow and a durable balance sheet, makes it a defensive anchor in a portfolio. Coupled with low valuation and a clear path to operational recovery, TGT offers both yield today and upside tomorrow.

Disclosure: I currently hold a position in Target Corporation (NASDAQ: $TGT). This article reflects my personal opinions and analysis, and is not intended as financial advice. Please conduct your own research or consult a financial advisor before making any investment decisions.

References

Corporate Target. (2025, June 12). Target Corporation increases quarterly dividend by 1.8 percent. Target Corporate. https://corporate.target.com/press/release/2025/06/target-corporation-increases-quarterly-dividend-by-1-8-percent

Corporate Target. (2025, August 21). Target Corporation reports second quarter 2025 earnings. Target Corporate. https://corporate.target.com/press/release/2025/08/target-corporation-reports-second-quarter-earnings

Koyfin. (2025). Target Corp (TGT) dividend overview. Koyfin. https://www.koyfin.com/company/tgt/dividends/

MarketBeat. (2025). Target financials (NYSE: TGT). MarketBeat. https://www.marketbeat.com/stocks/NYSE/TGT/financials/

Nasdaq. (2025, August 27). 1 green flag for Target stock right now. Nasdaq. https://www.nasdaq.com/articles/1-green-flag-target-stock-right-now-0

Stock Analysis. (2025). Target (TGT) dividend history and growth. Stock Analysis. https://stockanalysis.com/stocks/tgt/dividend/

Stock Analysis. (2025). Target balance sheet (TGT). Stock Analysis. https://stockanalysis.com/stocks/tgt/financials/balance-sheet/

TipRanks. (2025). Target dividend and payout ratio (TGT). TipRanks. https://www.tipranks.com/stocks/tgt/dividends

University of Iowa – Tippie College of Business. (2024). Target Corporation equity research report. https://www.biz.uiowa.edu/henry/download/f24_TGT.pdf

Pfizer’s Dividend Strengthens Case for Long-Term Investors

Posted on by
Reply

Pfizer Inc. ($PFE), one of the world’s largest pharmaceutical companies, continues to make a strong case for long-term investors seeking both stability and income. While the stock has faced recent volatility due to a decline in COVID-19 vaccine sales, its solid fundamentals, diversified pipeline, and consistent dividend payouts remain key reasons why investors may want to hold shares for the long haul.

Pfizer currently offers an attractive dividend yield—well above the S&P 500 average—making it a compelling choice for income-focused portfolios. The company has a long track record of reliable dividend payments and has shown commitment to rewarding shareholders even during periods of industry and market uncertainty. With a payout ratio supported by its robust cash flow, Pfizer’s dividend looks sustainable in the years ahead.

Beyond dividends, Pfizer’s pipeline of treatments in oncology, immunology, and rare diseases provides investors with growth opportunities outside of its COVID-19 products. Recent strategic acquisitions, such as the purchase of Seagen to bolster its oncology portfolio, reinforce the company’s long-term vision. These moves are designed to balance near-term headwinds with future revenue expansion.

Financial Snapshot: Strengths and Weaknesses

Strengths

  • Dividend Yield & Stability: Pfizer’s dividend yield is significantly higher than the S&P 500 average, appealing to income-focused investors.
  • Strong Balance Sheet: Despite recent revenue declines, Pfizer maintains healthy cash reserves and strong operating cash flow, supporting its dividend and acquisition strategy.
  • Attractive Valuation: Shares are trading at a discount compared to peers in the pharmaceutical sector, offering a margin of safety for value investors.
  • Diversified Revenue Base: Expansion in oncology, vaccines, and rare diseases provides multiple future growth drivers beyond COVID-19.

Weaknesses

  • COVID-19 Dependency Hangover: A sharp decline in vaccine and antiviral demand has pressured revenue, highlighting reliance on pandemic-era products.
  • R&D Risk: Heavy investment in research and development may not always lead to successful approvals, leaving earnings vulnerable.
  • Debt from Acquisitions: The Seagen deal adds to Pfizer’s debt load, which, while manageable, could strain resources if integration challenges arise.
  • Patent Expirations: Like many pharmaceutical giants, Pfizer faces long-term risks from patent cliffs that could erode future revenue streams.

Stock Price Outlook: 1 to 5 Years

Pfizer’s current share price reflects market concerns over post-COVID revenue declines, but its fundamentals suggest room for recovery.

  • 12-Month View (2025–2026): Analysts see potential for modest gains, with shares trading in the $32–$38 range as the market digests lower vaccine revenues but begins to price in oncology and pipeline growth. The dividend will continue to anchor returns even if share price growth is muted.
  • 3-Year View (2027): As new oncology therapies, rare-disease drugs, and vaccine innovations mature, Pfizer could see revenue stabilize and return to growth. A reasonable target range could be $40–$48 per share, supported by mid-single-digit revenue growth and steady dividends.
  • 5-Year View (2029–2030): If Pfizer successfully integrates Seagen, brings key drugs to market, and manages upcoming patent expirations, long-term investors could see shares trading in the $50–$60 range. Dividend reinvestment along the way would enhance total returns, making Pfizer a solid long-term hold for income plus growth.

While uncertainty remains in the short term, Pfizer’s combination of a reliable dividend, undervaluation relative to peers, and a promising pipeline suggests patient investors may be rewarded over a 5-year horizon.

Disclosure: I currently hold a position in Pifzer (NASDAQ: $PFE). This article reflects my personal opinions and analysis, and is not intended as financial advice. Please conduct your own research or consult a financial advisor before making any investment decisions.

Why More Families Are Turning to Trusts to Protect Their Assets

Posted on by
Reply

When it comes to protecting wealth and passing it on to loved ones, many families are discovering that a simple will may not be enough. Increasingly, individuals are turning to trusts as a more effective way to manage their assets and provide security for beneficiaries. While wills remain common, trusts offer unique advantages that make them an essential tool in modern estate planning.

A trust is a legal arrangement in which a trustee manages assets on behalf of beneficiaries. Unlike a will, which becomes public during probate, a trust can keep family financial matters private while ensuring assets are distributed according to the grantor’s wishes.

Avoiding Probate Delays and Costs
One of the main reasons individuals choose a trust is to avoid probate—the court-supervised process of distributing an estate after death. Probate can take months or even years, and legal fees can significantly reduce what heirs actually receive. With a trust, assets are transferred more quickly and with fewer administrative costs.

Tax Efficiency and Asset Protection
Certain types of trusts can also provide tax advantages. For high-net-worth individuals, this can mean minimizing estate taxes, while others use trusts to shield assets from creditors or lawsuits. Parents of minor children often create trusts to ensure their children’s financial needs are met in the event of an untimely death.

Control Over Distribution
Unlike a will, which typically results in a lump-sum transfer of assets, a trust allows for customized distribution. For example, beneficiaries can receive funds at certain ages, in installments, or for specific purposes such as education or healthcare. This level of control provides peace of mind for those worried about heirs’ financial responsibility.

Peace of Mind for Families
“Trusts aren’t just for the wealthy,” says estate planning attorney Sarah Mitchell. “They’re tools that provide structure, protection, and clarity—things every family can benefit from. For many clients, it’s about peace of mind knowing their loved ones are taken care of.”

As life expectancy increases and wealth is passed down through generations, experts predict that more families will explore trusts as part of their financial planning. Whether it’s avoiding probate, protecting assets, or ensuring responsible inheritance, trusts are becoming a cornerstone of modern estate planning.

About the Author:

David Dandaneau is a client relations analyst that covers the insurance and financial services industry. He is known for his insightful analysis and comprehensive coverage of market trends and regulatory developments.

A Brighter Outlook (Despite Skepticism): Could OSCR Reach $40 by Christmas 2025?

Posted on by
Reply

1. Highly Bullish Long-Term Forecasts

Some quantitative models project a steep upward trajectory. One forecasting service estimates an average December 2025 price of $34.67, with a low of $32.18 and a high of $35.72—implying over 100% upside from current levels (StockScan). If investor sentiment catches up with this model, the stock could indeed flirt with $40 before year-end.

2. Financing Strength and Cash Position

As of March 31, 2025, Oscar Health reported a fortified balance sheet: $4.86 billion in cash, equivalents, and investments, up from $3.97 billion at the end of 2024. Total assets rose 21% YoY, while operating cash flow increased 38% (Michael Burry’s Insights). This cash cushion gives Oscar flexibility to invest in growth, navigate regulatory headwinds, and drive further value.

3. Strategic Expansion Through New Partnerships

Oscar’s deal with Hy-Vee to launch “Hy-Vee Health with Oscar” in Des Moines, covering about 400,000 employees in the individual marketplace starting Jan 1, 2026, signals a bold move into employer-backed coverage. The ICHRA model aims to save businesses 20–30% and deliver substantial cost-savings to employees-this could create significant scale and margin tailwinds (Benzinga).

4. Accelerating Revenue Growth

While Q2 revenue of $2.86 billion fell slightly short of the $2.91 billion estimate, it still marked a 29% increase YoY. The company reaffirmed its full-year 2025 revenue guidance at $12–12.2 billion (versus Wall Street’s $11.32 billion estimate), underscoring underlying growth momentum (BenzingaYahoo FinanceStockAnalysis).

5. Valuation Appears Undervalued for Growth Potential

Oscar trades at over 101x forward EV/EBITDA, a lofty multiple—but some analysts argue this valuation is justified by its “quality characteristics” and disruptive business model (StockStory). Others see it as deeply undervalued despite near-term uncertainty tied to ACA policy risks (Seeking Alpha+1).

Why Analysts Are Still Cautious

  • Low Analyst Price Targets: Consensus 12-month forecasts range between $8 and $14, with averages clustered around $11–$12—well below the $40 mark (ZacksThe Wall Street JournalPriceTargetsInvesting.com).
  • Skeptical Market Sentiment: Many brokerages hold “Sell,” “Hold,” or “Neutral” ratings. Notably, Piper Sandler cut its target from $14 to $13, citing uncertainties around risk adjustments and path to profitability (Benzinga). MarketBeat’s consensus is “Strong Sell,” and TipRanks flags a “Downside potential” of ~30% (MarketBeat).
  • Profitability Still Out of Reach in 2025: OSCR is expected to operate at a loss—losses projected around $200–300 million for the year (Yahoo Finance). Its Q2 GAAP loss was $0.89/share, and medical loss ratio (MLR) swelled from 79% in 2024 to 91.1% in Q2 2025 (BenzingaStockAnalysis). These factors dampen bullish expectations.

Headlines-Style Article: “Oscar Health: Can It Make the Leap to $40 by Christmas 2025?”

New York, August 23, 2025 – Oscar Health Inc. (NYSE: OSCR) currently trades near $16.98, buoyed by stellar revenue growth, robust liquidity, and a landmark new partnership but Wall Street’s confidence remains tepid.

Why $40 isn’t implausible:

  • Long-term algorithmic forecasts place December 2025 prices in the low-$30s, including a possible high of $35.72 (StockScan).
  • Strengthened cash position of $4.86 billion, coupled with rising operating cash flows, enhances the company’s financial flexibility (Michael Burry’s Insights).
  • Innovative ventures like the Hy-Vee collaboration, targeting 400,000 employees, position Oscar to disrupt cost structures and tap new revenue streams (Benzinga).
  • A confirmed revenue guidance of $12–12.2 billion highlights strong underlying demand despite macro-healthcare headwinds (Yahoo FinanceStockAnalysis).

But hurdles remain:

  • Analyst targets remain pessimistic, ranging mostly between $8 and $14, with an average nearer $11–12 (ZacksThe Wall Street JournalPriceTargetsInvesting.com).
  • Profitability is still elusive: projected operational losses of up to $300 million in 2025, and increased medical loss ratios (MLR) eroding margins (BenzingaYahoo FinanceStockAnalysis).
  • Sentiment skews negative, with ratings from “Hold” to “Strong Sell” prevailing, reflecting elevated policy-related and insurance-market risks (MarketBeat).

Final Thoughts: While consensus targets place Oscar Health under $15, a confluence of strong cash reserves, growth initiatives, and bullish long-term models could propel the stock into the low $30s by Christmas-though doing so would require sustained execution and favorable market sentiment in the face of continued near-term challenges.

Disclaimer: The author holds a position in $OSCR Oscar Healthcare and this article should not be considered financial advice. Always conduct your own research before making any investment decisions.

References

Benzinga. (2025, August 20). Oscar Health faces analyst questions on path to profitability. Benzinga. https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/08/47133490/oscar-health-faces-analyst-questions-on-path-to-profitability

Benzinga. (2025, August 21). What’s going on with Oscar Health stock on Wednesday? Benzinga. https://www.benzinga.com/news/health-care/25/08/47240234/whats-going-on-with-oscar-health-stock-on-wednesday

Finance Yahoo. (2025, August 19). Oscar Health (OSCR) updates 2025 revenue guidance. Yahoo! Finance. https://finance.yahoo.com/news/oscar-health-oscr-updates-2025-174216635.html

MarketBeat. (2025). Oscar Health analyst ratings and price targets. MarketBeat. https://www.marketbeat.com/stocks/NYSE/OSCR/

Michael-Burry.com. (2025, August). Oscar Health stock analysis. Michael-Burry.com. https://www.michael-burry.com/oscr-stock-analysis/

Seeking Alpha. (2025, July 30). Oscar Health stock: Undervalued, but not without risk. Seeking Alpha. https://seekingalpha.com/article/4814520-oscar-health-stock-undervalued-but-not-without-risk

Stockanalysis.com. (2025). Oscar Health (OSCR) financials and stock data. Stock Analysis. https://stockanalysis.com/stocks/oscr/

Stockscan.io. (2025). Oscar Health stock forecast. StockScan. https://stockscan.io/stocks/OSCR/forecast

StockStory.org. (2025). Oscar Health stock insights. StockStory. https://stockstory.org/us/stocks/nyse/oscr

The Wall Street Journal. (2025). Oscar Health Inc. research ratings & reports. WSJ. https://www.wsj.com/market-data/quotes/OSCR/research-ratings

Zacks Investment Research. (2025). Oscar Health (OSCR) price targets & forecasts. Zacks. https://www.zacks.com/stock/research/OSCR/price-target-stock-forecast

Why Airbnb (ABNB) Might Be a Strong Long-Term Investment

Posted on by
Reply

1. Robust Financials & Market Leadership

Airbnb delivered $11.1 billion in revenue for 2024, marking a 12% year-over-year increase, driven by higher booking volume and sustained average daily rates. Gross booking value surged to $81.8 billion (+10.6% YoY), while free cash flow hit $458 million in Q4 (18% margin) (AInvest).

Moreover, Airbnb’s global market share in short-term rentals climbed to 44% in 2024, up from 28% in 2019—far ahead of Booking.com (18%) and Expedia/Vrbo (9%) (AInvest).

2. Efficient Asset-Light Business Model

Airbnb’s strategy avoids owning properties, enabling high-margin operations. Their gross margin soared to approximately 83% in early 2024 (The Motley Fool), and their asset utilization metrics demonstrate tightening efficiency. Notably, the net fixed-asset turnover leaped from 12.5 in 2020 to 75.5 in 2024, reflecting strong revenue delivery with minimal asset base (Stock Analysis on Net).

3. Strategic Diversification into Services & Experiences

In recent quarters, Airbnb has repositioned itself beyond homestays into an integrated travel ecosystem-offering localized experiences, services like spa treatments, personal training, and lodging alternatives-all within its revamped app ecosystem (AInvestMarketWatch).

This diversification is not trivial: management projects that the “Services & Experiences” vertical could generate $1 billion in annual revenue within 3–5 years, backed by a $200–250 million investment earmarked for 2025 (AInvestMarketWatch).

4. Recent Strong Earnings Momentum

Airbnb outperformed expectations in Q2 2025:

  • Earnings per share: $1.03 (+99% YoY vs. $0.94 expected)
  • Revenue: $3.1 billion (+13% YoY)
  • Gross bookings: $23.5 billion (+11% YoY)

Despite these strong results, caution around margin trajectory and investment pace weighed on sentiment, causing a ~7% dip in premarket trading Investors.

Simultaneously, long-term confidence remains steady-Akre Capital boosted its Airbnb allocation by 10%, signaling belief in the company’s growth trajectory (AInvest).

5. Favorable Industry Trends

In the broader travel space, analysts remain positive. A recent Barron’s feature highlights secular travel growth outpacing GDP and the rising demand for experiences. Although other travel players like hotels and airlines benefit, OTAs and platforms like Airbnb must adapt and diversify to stay competitive-something Airbnb is actively doing (Barron’s).

Industry Positioning: How Airbnb Compares

Here’s a snapshot comparing Airbnb to its main competitors in the travel lodging and experiences sector:

CompanyMarket Share (2024)Business ModelKey Differentiator
Airbnb44%Asset-light platformLarge host network, high margins, diversified services
Booking.com18%Hybrid (hotels + rentals)Strong hotel partnerships, AI integration
Expedia/Vrbo9%Hybrid OTABundle offerings, traditional OTA presence

Airbnb leads clearly in short-term rental share and continues to build stronger differentiation through vertical integration and digital enhancements (AInvest+1MarketWatchBarron’s).

Points of Caution

  • Valuation: Forward P/E sits above 30x (e.g., ~34.5x), relatively high compared to peers like Expedia (~10x) or Booking (~18x) (The Motley FooleToro).
  • Regulatory Headwinds: Local restrictions (e.g., New York City) and evolving laws could curtail growth in certain markets (eToroMarketWatch).
  • Execution Risk: Scaling new offerings and achieving the $1 billion services target will take time—short-term margins may remain under pressure (AInvestInvestorsMarketWatch).

Final Take

Airbnb demonstrates the hallmarks of a high-upside, long-term growth stock:

  • Strong financials, efficient operations, and leading share in a growing market.
  • Expanding revenue streams beyond traditional listings.
  • Strategic execution evidenced by earnings beats and fund manager conviction.

That said, elevated valuation and near-term execution risks suggest that patient investors may benefit from disciplined entry points or staged allocation.

Disclaimer: The author holds a position in $ABNB AIR BNB and this article should not be considered financial advice. Always conduct your own research before making any investment decisions.

References

Ainvest. (2025, February 8). Airbnb resilient growth: Deep dive into profitability, market share, and long-term competitive positioning. Ainvest. https://www.ainvest.com/news/airbnb-resilient-growth-deep-dive-profitability-market-share-long-term-competitive-positioning-2508

Ainvest. (2025, February 8). Airbnb’s strategic shift: Competing with hotels and expanding into services. Ainvest. https://www.ainvest.com/news/airbnb-strategic-shift-competing-hotels-expanding-services-2508

Ainvest. (2025, February 8). Akre Capital’s sudden 53% cut in American Tower: A signal or a slip? Ainvest. https://www.ainvest.com/news/akre-capital-sudden-53-cut-american-tower-signal-slip-2508

Barron’s. (2025, February 10). Travel stocks are surging. United, Delta, Hyatt, and more stand out. Barron’s. https://www.barrons.com/articles/travel-stocks-united-delta-hyatt-cb139268

EToro. (2024, August 12). Analyzing Airbnb’s Q2 2024 earnings report. eToro. https://www.etoro.com/news-and-analysis/market-insights/analyzing-airbnbs-q2-2024

Fool.com. (2025, January 26). I just bought Airbnb stock for the 1st time since the IPO. Here’s why. The Motley Fool. https://www.fool.com/investing/2025/01/26/i-just-bought-airbnb-stock-for-the-1st-time-since

Fool.com. (2025, February 27). 3 must-know reasons to buy Airbnb—and 1 reason to be cautious. The Motley Fool. https://www.fool.com/investing/2025/02/27/3-must-know-reasons-to-buy-airbnb-and-1-reason

Investors.com. (2025, August 13). Airbnb growth accelerates as Q2 earnings beat. Why the stock is falling anyway. Investor’s Business Daily. https://www.investors.com/news/technology/airbnb-stock-abnb-q2-2025-earnings-news

MarketWatch. (2025, February 5). Airbnb wants to be an “anything” app. The debate for investors hinges on these issues. MarketWatch. https://www.marketwatch.com/story/airbnb-wants-to-be-an-anything-app-the-debate-for-investors-hinges-on-these-issues-ca692140

Stock-Analysis-On.net. (2025). Airbnb Inc. long-term investment activity ratios. Stock Analysis On. https://www.stock-analysis-on.net/NASDAQ/Company/Airbnb-Inc/Ratios/Long-term-Investment-Activity

Why Apple Stock Remains a Strong Buy in 2025

Posted on by
Reply

Apple remains a compelling long-term investment, thanks to its robust ecosystem, accelerating AI strategy, and disciplined capital returns.

🏛️ Reliable Business Model & Ecosystem Moat

Apple now supports over 2.3 billion active devices, forming one of the most durable customer ecosystems in tech. This massive footprint reinforces high switching costs and recurring revenue streams via services like the App Store, Apple Pay, and suite of subscriptions (now over 38% of gross profit) (Forbes). Its strategy of integrating hardware, software, and services creates a differentiation moat that’s hard to replicate.

🚀 Catalysts Behind Future Growth

▪ Apple Intelligence: A Privacy-First AI Pivot

At WWDC 2025, Apple unveiled its “Apple Intelligence” initiative—20+ AI-powered features like real-time translation and email summarization designed for on-device performance and privacy. A major upgrade to Siri is expected in 2026. While it’s lagging peers in sheer AI spend, Apple is now investing aggressively and open to strategic M&A, having acquired at least seven AI startups in 2025..

▪ iPhone Refresh Cycles & Hardware Upside

Morgan Stanley projects a 12% rebound in iPhone shipments by fiscal 2026 as AI features boost upgrade demand. The favorable reception to new iPhone 16 models ahead of the holiday season supports this optimistic view (marketwatch.com).

🌍 Strategic Resilience Amid Geopolitical Risks

Apple’s architecture strategy includes over $500 billion in U.S. investment over four years—from expanding chip-making capacity to creating manufacturing academies and AI server production facilities to help offset tariff risks. At the same time, it has shifted much iPhone production for U.S. markets to India, diversifying supply chain risk away from China.

💰 Financial Strength & Shareholder Returns

Apple posted $94 billion in Q3 2025 revenue—a 10% year-over-year gain—and services revenue reached a record $27.4 billion. EPS came in above expectations, and despite $800 million+ in tariff impacts, Apple demonstrated operational resilience.

It continues to return capital aggressively, with $15.2 billion paid in dividends in 2025 and a long-term track record of dividend increases and share repurchases. Analysts expect this capital discipline to endure, offering downside protection and steady income (The Motley FoolForbes).

📉 Valuation: Discount with Upside Potential

Despite its strengths, Apple is currently down roughly 20% year-to-date, underperforming other major tech names amid tariff fears, AI lags, and macro uncertainty (Business Insider). Its forward P/E sits at around 33.6×, above the S&P 500 average (~23×), making valuation relative to its growth prospects a mixed story (Forbes). Still, analysts at BofA, Goldman Sachs, Wedbush, and others issue “Buy” ratings with 12–18 month targets of $235–300, implying double-digit upside from today’s ~$200 price levels.

🧭 Risks to Watch

While Apple’s fundamentals remain solid, investors should monitor:

  • Delays or execution risk in AI deployment or acquisitions
  • Regulatory scrutiny around antitrust, App Store rules, and global expansion
  • U.S.–China relations and implications for supply chain resilience

📈 Final Verdict: Long-Term Buy, Tactical Caution

Apple’s dominant ecosystem, balanced growth from hardware and high-margin services, disciplined capital returns, and accelerated AI pivot position it as a long-term winner. While near-term volatility and tariff uncertainty add caution, the current valuation discount provides an attractive entry point for investors with a multiyear horizon.

Disclosure:

I do not own any stock or have any financial interest in Apple Inc. (NYSE: AAPL). This article is for informational purposes only and should not be considered financial or investment advice. Investing in stocks carries risks, and past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial professional before making any investment decisions.

📚 References

Apple Inc. (2025, February 24). Apple will spend more than $500 billion USD in the US over the next four years. Apple Newsroom. https://www.apple.com/newsroom/2025/02/apple-will-spend-more-than-500-billion-usd-in-the-us-over-the-next-four-years/

Barrons. (2025, August 1). Apple stock has ‘significant,’ long-term opportunities. The case for buying now. Barrons. https://www.barrons.com/articles/apple-stock-ai-value-buy-6a2ee154

Business Insider. (2025, May 1). Apple is the worst-performing Mag 7 stock this year. Here’s what analysts and investors say about whether you should buy the dip. Business Insider. https://www.businessinsider.com/apple-stock-price-outlook-aapl-mag-7-buy-the-dip-2025-5

Business Insider. (2025, July 31). Apple Q3 earnings: iPhone demand, AI, and tariffs. Business Insider. https://www.businessinsider.com/apple-q3-earnings-aapl-stock-price-iphone-demand-ai-tariffs-2025-7

Cinco Días. (2025, August 1). Apple aumenta su inversión en IA y compras estratégicas. Cinco Días. https://cincodias.elpais.com/smartlife/lifestyle/2025-08-01/apple-ia-aumento-inversion-compras.html

Forbes. (2025, July 12). Where will Apple (AAPL) stock be in 5 years? Forbes. https://www.forbes.com/sites/investor-hub/article/where-will-apple-aapl-stock-be-in-5-years/

Lens LunarTech. (2025). Apple’s 2025 playbook: Navigating tariffs, expanding manufacturing, and sustaining growth. LunarTech Lens. https://lens.lunartech.ai/post/apples-2025-playbook-navigating-tariffs-expanding-manufacturing-and-sustaining-growth

MarketWatch. (2025). Apple bears have missed out on more than $1 trillion of stock gains, says this bull. MarketWatch. https://www.marketwatch.com/story/apple-bears-have-missed-out-on-more-than-1-trillion-of-stock-gains-says-this-bull-41116074

Panmore Institute. (n.d.). Apple Inc.’s generic strategy & intensive growth strategies. Panmore Institute. https://panmore.com/apple-inc-generic-strategy-intensive-growth-strategies

HBAR Hedera Makes Gains Amid Bullish Market: Can It Hit $1 in 2025?

Posted on by
Reply

May 13, 2025 — Hedera Hashgraph ($HBAR), the native cryptocurrency of the Hedera network, is drawing renewed attention as it experiences a resurgence in price and market confidence. As of today, HBAR is trading at $0.2098, down slightly by 1.88% over the last 24 hours. This comes after a strong performance earlier in the week, where the token climbed over 24%, breaking the psychological barrier of $0.20 and signaling potential bullish momentum.

Current Market Snapshot

  • Price: $0.2098
  • 24H Change: -1.88%
  • Day High / Low: $0.2266 / $0.2015
  • Market Sentiment: Cautiously optimistic

HBAR has been trading within a broad range but recently found support near the $0.20 level, which analysts say could serve as a foundation for further gains—assuming favorable market conditions persist.

Bullish Outlook & Price Predictions
Several crypto analysts and financial platforms forecast a promising future for HBAR in the ongoing bull cycle. According to analysts at Crypto News and Bankless Times, Hedera could surge toward $1, particularly if it breaks key resistance levels near $0.30 and $0.58—the latter being its all-time high.

One analyst noted: “If the current upward momentum sustains, and with growing enterprise adoption—including partnerships with tech giants like Google and IBM—HBAR could challenge the $1 mark by late 2025.” (Crypto News, 2025)

Others remain more conservative, citing continued challenges in breaking out of the long-term descending channel as a key risk. Technical indicators such as the Relative Strength Index (RSI) and Chaikin Money Flow show strong market inflows, but overbought conditions may spark a short-term pullback.

Fundamentals Supporting Growth
Several factors bolster HBAR’s long-term appeal:

  • Enterprise Integrations: Use by Fortune 500 companies.
  • Sustainability: Hedera’s consensus mechanism is significantly energy-efficient compared to traditional blockchains.
  • Tokenization and DeFi Growth: Hedera’s total value locked (TVL) in stablecoins has recently surged to $130 million, up from just $37 million at the start of the year (Crypto News, 2025).

Hedera’s price trajectory appears increasingly bullish, but market watchers remain wary of resistance zones and macroeconomic headwinds. Whether HBAR reaches $1 this year depends largely on continued investor sentiment, enterprise adoption, and overall crypto market dynamics.

Disclaimer: The author holds a position in HBAR Hedera Hashgraph and this article should not be considered financial advice. Always conduct your own research before making any investment decisions.

References

BeInCrypto. (2025, May 12). Hedera HBAR price secures $0.20 support as funding rate hits 5-month high. https://beincrypto.com/hedera-hbar-price-secures-support-funding-rate-rises/

Bankless Times. (2025, January 29). Top 3 reasons the Hedera HBAR price may surge to $2.50 in 2025. https://www.banklesstimes.com/articles/2025/01/29/top-3-reasons-the-hedera-hbar-price-may-surge-to-2-50-in-2025/

CCN. (2025, May). Hedera HBAR price prediction. https://www.ccn.com/analysis/crypto/hedera-hbar-price-prediction/

CoinMarketCap. (2025, May). HBAR price forecast by Cheeky Crypto. https://coinmarketcap.com/academy/article/9b874a2f-5038-49e0-aee8-a75b150d6b99

Crypto News. (2025, May). HBAR price prediction: Can Hedera hit $1 in this bull market? https://crypto.news/hbar-price-prediction-can-hedera-hit-in-this-bull-market/

Crypto News. (2025, May). HBAR stablecoin market cap surges. https://crypto.news/hbar-crypto-price-prediction-as-hedera-stablecoin-market-cap-surges/

The Crypto Basic. (2025, January 20). Hedera price prediction: Analysts forecast $5 HBAR by 2025. https://thecryptobasic.com/2025/01/20/hedera-price-prediction-analysts-forecast-5-hbar-by-2025/